What the future may hold for the treatment of renal cell carcinoma
The following article from OncLive discusses the rapidly changing landscape in [...]
Immunotherapy combinations for advanced kidney cancer
The following two videos from OncLive are interviews with two [...]
ASTRO 2018: Stereotactic radiotherapy proves safe and effective for kidney cancer patients with one kidney
The results from a study shows stereotactic ablative radiotherapy (SABR) [...]
Active smoking shortens overall survival in metastatic kidney cancer patients treated with TKIs
We already know that smoking may increase the risk of [...]
ESMO 2018: Assessment of asymptomatic brain metastases in kidney cancer patients
The results of an analysis of renal cell carcinoma (RCC) [...]
Radical versus partial nephrectomy for early stage kidney cancer
A recent study involving 2,459 people who had a partial [...]
ESMO 2018: Cabozantinib/atezolizumab combination shows encouraging clinical activity for untreated advanced RCC
Results from the phase 1b COSMIC-021 study of cabozantinib in [...]
ESMO 2018: Longer treatment-free survival for ipilimumab/nivolumab combination versus sunitinib
Analysis of the phase 3 CheckMate-214 study has shown that [...]
ESMO 2018: Axitinib for the treatment of metastatic papillary renal cell carcinoma in the first-line
The results from a phase 2 clinical trial to assess [...]
ESMO 2018: Cabozantinib is effective in advanced RCC regardless of PD-L1 expression
An analysis of the data from the CABOSUN and METEOR [...]
